Role of Cognitive Enhancer Therapy in Alzheimer’s Disease with Concomitant Cerebral White Matter Disease: Findings from a Long-Term Naturalistic Study

BACKGROUND: Evidence is lacking for cognitive enhancer therapy in patients with Alzheimer’s disease (AD) and concomitant cerebrovascular disease (mixed AD) as such patients would have been excluded from clinical trials. Earlier studies of mixed AD have focused on large vessel cerebrovascular disease...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Ng, Kok Pin, Ng, Aloysius, Assam, Pryseley, Heng, Esther, Kandiah, Nagaendran
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer International Publishing 2014
Gaiak:
Original Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4153975/
https://ncbi.nlm.nih.gov/pubmed/25063270
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40268-014-0057-5
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak